Enliven Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29337E1029
USD
60.27
0.57 (0.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryEnliven Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
0.95%
0.62%
1W
11.71%
3.58%
1M
20.52%
3.38%
YTD
291.36%
13.32%
1Y
219.9%
22.36%
3Y
232.43%
71.69%
5Y
160.23%
74.86%
10Y
%
255.39%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
46.29%
0%
46.29%
6 Months
104.86%
0%
104.86%
1 Year
219.9%
0%
219.9%
2 Years
174.83%
0%
174.83%
3 Years
232.43%
0%
232.43%
4 Years
1115.12%
0%
1115.12%
5 Years
160.23%
0%
160.23%

Enliven Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary